Related Experiment Videos
Plasma triglyceride as a risk factor for cardiovascular disease
1Department of Epidemiology, University of Washington, Seattle 98195, USA. maustin@u.washington.edu
The Canadian Journal of Cardiology
|June 17, 1998
Summary
Elevated plasma triglyceride levels predict cardiovascular disease risk independently of high-density lipoprotein cholesterol. Further clinical trials are needed to confirm if reducing triglycerides lowers this risk.
Area of Science:
- Cardiovascular Epidemiology
- Lipid Metabolism
- Preventive Cardiology
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
- The role of plasma triglyceride levels in CVD risk prediction, independent of high-density lipoprotein (HDL) cholesterol, requires clarification.
Purpose of the Study:
- To investigate whether plasma triglyceride levels predict cardiovascular disease risk independently of high-density lipoprotein (HDL) cholesterol levels.
Main Methods:
- A meta-analysis of 17 prospective population-based studies (over 57,000 participants, men and women) published between 1965 and 1994.
- Relative risks (RR) for cardiovascular disease associated with triglyceride levels were estimated and standardized.
- Weighted average RRs were calculated, with and without adjustment for HDL cholesterol.
Main Results:
- Increased triglyceride levels were associated with a significantly higher risk of cardiovascular disease in both men (RR=1.32) and women (RR=1.76).
- The association remained statistically significant in men even after adjusting for HDL cholesterol (adjusted RR=1.14).
- In women, the triglyceride-CVD association also remained significant after HDL cholesterol adjustment (adjusted RR=1.37).
Conclusions:
- Elevated plasma triglyceride levels are an independent risk factor for cardiovascular disease.
- Further clinical trials are essential to determine the efficacy of lowering plasma triglyceride levels in reducing cardiovascular disease risk.